Association between Systemic Factors and Vitreous Fluid Cytokines in Proliferative Diabetic Retinopathy

J Clin Med. 2023 Mar 17;12(6):2354. doi: 10.3390/jcm12062354.

Abstract

Proliferative diabetic retinopathy (PDR) is a vision-threatening complication of diabetes mellitus (DM). Systemic and intraocular factors are intricately related to PDR, and vitreous fluid (VF) cytokines are representative intraocular biomarkers. However, the associations between systemic factors and VF cytokines and their influence on PDR pathology are unclear. This study aimed to examine the correlation between systemic factors and VF cytokines and analyze their contributions to the pathology of PDR using multivariate analyses. We conducted a retrospective observational study on 26 PDR eyes of 25 patients with type 2 DM, and 30 eyes of 30 patients with idiopathic macular hole or epiretinal membrane as controls. Fifteen systemic and laboratory tests including blood pressure (BP) and body mass index (BMI), and 27 cytokines in VF were analyzed. BP and BMI correlated positively with VF levels of IL-6 and IP-10 in PDR patients, while no significant correlation was found between systemic factors and VF cytokines in controls. MCP-1 and VEGF-A in VF separately clustered with different systemic factors in controls, but these cytokines lost the property similarity with systemic factors and acquired property similarity with each other in PDR. Systemic factors contributed to only 10.4%, whereas VF cytokines contributed to 42.3% out of 52.7% variance of the whole PDR dataset. Our results suggest that intraocular factors play a major role in the pathology of PDR, whereas systemic factors may have limited effects, and that BP and BMI control in PDR could be useful interventions to improve intraocular immune condition.

Keywords: blood pressure; body mass index; influence; interleukin-6; monocyte chemoattractant protein-1; proliferative diabetic retinopathy; vascular endothelial growth factor; vitreous fluid cytokine.

Grants and funding

This study was supported by The Uehara Memorial Foundation; a Grant-in-Aid for Scientific Research C from the Japan Society for the Promotion of Science (16K11337); a Grant-in-Aid for Encouragement of Young doctors from National Defense Medical College; Research Grant from Daiwa Securities Health Foundation; Hisakichi Matsubayashi Memorial Fund Subsidy; a Grant-in-Aid for Advanced Medical Development from National Defense Medical College; Novartis Research Grant; and Alcon Research Grant.